| Trial ID: | L0619 |
| Source ID: | NCT02290106
|
| Associated Drug: |
Pitavastatin
|
| Title: |
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
Has Results
|
| Results: |
https://clinicaltrials.gov/ct2/show/results/NCT02290106
|
| Conditions: |
Obesity;Fatty Liver, Nonalcoholic
|
| Interventions: |
Drug: pitavastatin;Other: PLACEBO
|
| Outcome Measures: |
Insulin-stimulated Glucose Uptake;Liver FatAlanine Aminotransferase (ALT);Aspartate Aminotransferase (AST);Hepatic Insulin Sensitivity;Hemoglobin A1c (HbA1c);Quantitative Insulin Sensitivity Check Index (QUICKI)
|
| Sponsor/Collaborators: |
Massachusetts General Hospital
|
| Gender: |
Male
|
| Age: |
40 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
08/11/2014
|
| Completion Date: |
--
|
| Results First Posted: |
02/07/2019
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02290106
|
